Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment Post published:August 24, 2022 Post category:Press Release
Algernon Pharmaceuticalsā Largest Shareholder AlphaNorth Asset Management Increases Ownership Position Post published:August 24, 2022 Post category:Press Release
GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates Post published:August 23, 2022 Post category:Press Release
Opinions | The Psychedelic Community Takes Itself Too Seriously Post published:August 22, 2022 Post category:Opinions
Algernon Pharmaceuticals Announces Private Placement Post published:August 20, 2022 Post category:Press Release
Psychedelic Bulletin #115 – Mydecine Looks Set to Shutter; MindMed Gains ‘Meme Stock’ Status; atai ‘Streamlilnes’ Pipeline; California Decrim. Bill Gutted Post published:August 19, 2022 Post category:Psychedelic Bulletin
HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendmentsā and the Issuance of Shares for Debt Post published:August 19, 2022 Post category:Press Release
Bright Minds Biosciences Comments on Recent Trading Activity Post published:August 18, 2022 Post category:Press Release
Small Pharma Announces TSXV Approval of Normal Course Issuer Bid Post published:August 18, 2022 Post category:Press Release